Thrombolytic TherapyStreptokinaseTissue Plasminogen ActivatorFibrinolytic AgentsMyocardial InfarctionAntibiotic ProphylaxisPlasminogen ActivatorsAnistreplaseUrokinase-Type Plasminogen ActivatorPulmonary EmbolismStrokeTreatment OutcomeBrain IschemiaHeparinTime FactorsCerebral HemorrhageMyocardial ReperfusionThrombosisEmbolectomyAcute DiseasePost-Exposure ProphylaxisCoronary Care UnitsHemorrhageFibrinolysisProspective StudiesHeart Rupture, Post-InfarctionIntracranial ThrombosisIntracranial HemorrhagesElectrocardiographyVenous ThrombosisRecurrenceAnticoagulantsInfusions, IntravenousAngioplasty, Balloon, CoronaryFibrinolysinCarotid Artery ThrombosisRetrospective StudiesInjections, IntravenousCoronary ThrombosisRecombinant ProteinsEmergency Medical ServicesCoronary AngiographyIntracranial Embolism and ThrombosisEmergenciesVascular PatencyTomography, X-Ray ComputedEmergency TreatmentInfusions, Intra-ArterialDental ProphylaxisIntracranial EmbolismFollow-Up StudiesCerebral InfarctionHirudin TherapyCreatine KinaseEmergency Medical TechniciansRadionuclide VentriculographyRisk FactorsHospital MortalityDrug Therapy, CombinationInjections, Intra-ArterialRandomized Controlled Trials as TopicThrombectomyReperfusionFibrinopeptide ACerebral AngiographySurvival AnalysisFibrinogenPatient SelectionFibrinEye HemorrhageAspirinNewfoundland and LabradorThromboembolismHeart RuptureCatheterization, PeripheralStreptodornase and StreptokinaseAngiographyPredictive Value of TestsPrognosisChemopreventionBlood CoagulationThrombophlebitisCerebrovascular DisordersEcchymosisInfarction, Middle Cerebral ArteryHospitals, CommunityArterial Occlusive DiseasesIncidenceSurvival RatePremedicationFibrin Fibrinogen Degradation ProductsMultivariate AnalysisDouble-Blind MethodCardiac CatheterizationShock, CardiogenicVentricular Septal RuptureRegistriesPlasminogenDrug Administration ScheduleInfarction, Anterior Cerebral Artery